Published in J Clin Microbiol on December 24, 2008
Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations. J Virol (2010) 1.71
A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses. PLoS Pathog (2011) 1.63
Evolution and diversity in human herpes simplex virus genomes. J Virol (2013) 1.35
Genomic, phylogenetic, and recombinational characterization of herpes simplex virus 2 strains. J Virol (2015) 0.87
Molecular characterization of herpes simplex virus 2 strains by analysis of microsatellite polymorphism. J Clin Microbiol (2013) 0.81
Identifying the viral genes encoding envelope glycoproteins for differentiation of Cyprinid herpesvirus 3 isolates. Viruses (2013) 0.81
Genotyping of a microsatellite locus to differentiate clinical Ostreid herpesvirus 1 specimens. Vet Res (2014) 0.79
In- silico exploration of thirty alphavirus genomes for analysis of the simple sequence repeats. Meta Gene (2014) 0.77
Molecular method development and establishment of a database for clinical and epidemiological herpes simplex virus 1 strain comparisons. J Clin Microbiol (2014) 0.77
Genetic variability in the region encompassing reiteration VII of herpes simplex virus type 1, including deletions and multiplications related to recombination between direct repeats. Springerplus (2015) 0.75
Genome-wide In Silico Analysis, Characterization and Identification of Microsatellites in Spodoptera littoralis Multiple nucleopolyhedrovirus (SpliMNPV). Sci Rep (2016) 0.75
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25
Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components. Proc Natl Acad Sci U S A (1975) 10.59
Simple sequences are ubiquitous repetitive components of eukaryotic genomes. Nucleic Acids Res (1984) 6.93
Repair tracts in mismatched DNA heteroduplexes. Proc Natl Acad Sci U S A (1976) 5.88
Microsatellites within genes: structure, function, and evolution. Mol Biol Evol (2004) 5.01
Genital herpes. Lancet (2007) 3.83
Nucleotide sequences of the joint between the L and S segments of herpes simplex virus types 1 and 2. J Gen Virol (1981) 3.70
The herpes simplex virus 1 gene for ICP34.5, which maps in inverted repeats, is conserved in several limited-passage isolates but not in strain 17syn+. J Virol (1990) 3.16
Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak. J Infect Dis (1978) 3.00
The DNA sequences of the long repeat region and adjoining parts of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 2.50
Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med (2007) 2.27
DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc Natl Acad Sci U S A (2005) 2.20
Herpes simplex virus type 1 UL46 and UL47 deletion mutants lack VP11 and VP12 or VP13 and VP14, respectively, and exhibit altered viral thymidine kinase expression. J Virol (1993) 1.99
Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J Gen Virol (1994) 1.79
Long, polymorphic microsatellites in simple organisms. Proc Biol Sci (1996) 1.75
Identification of three genes nonessential for growth in cell culture near the right terminus of the unique sequences of long component of herpes simplex virus 1. Virology (1990) 1.62
Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses. J Virol (2004) 1.51
Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J Virol (1997) 1.44
Transmission of herpes-simplex virus type 1 in a nursery for the newborn. Identification of viral isolates by D.N.A. "fingerprinting". Lancet (1978) 1.40
A tandemly reiterated DNA sequence in the long repeat region of herpes simplex virus type 1 found in close proximity to immediate-early mRNA 1. J Virol (1984) 1.39
High recombination rate in herpes simplex virus type 1 natural populations suggests significant co-infection. Infect Genet Evol (2004) 1.23
Restriction endonuclease patterns of herpes simplex virus DNA: application to diagnosis and molecular epidemiology. Curr Top Microbiol Immunol (1983) 1.18
Herpes simplex virus 1 transmission through corneal transplantation. Lancet (2001) 1.18
Temporal cluster of herpes simplex encephalitis: investigation by restriction endonuclease cleavage of viral DNA. J Infect Dis (1980) 1.17
Persistence of repeated sequences that evolve by replication slippage. Genetics (1992) 1.14
A herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivo. Proc Natl Acad Sci U S A (2000) 1.08
Genomic comparison of herpes simplex virus type 1 isolates from Japan, Sweden and Kenya. J Gen Virol (1987) 1.05
Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent restriction fragment length polymorphism analysis. Zentralbl Bakteriol (1994) 1.03
Numerous length polymorphisms at short tandem repeats in human cytomegalovirus. J Virol (1999) 1.03
Contribution of the 3'- to 5'-exonuclease activity of herpes simplex virus type 1 DNA polymerase to the fidelity of DNA synthesis. J Biol Chem (2004) 1.03
Amplification of reiterated sequences of herpes simplex virus type 1 (HSV-1) genome to discriminate between clinical HSV-1 isolates. J Clin Microbiol (1999) 1.00
Variability of the glycoprotein G gene in clinical isolates of herpes simplex virus type 1. Clin Diagn Lab Immunol (1999) 0.98
Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase. J Virol (2006) 0.97
Nosocomial herpetic infections in a pediatric intensive care unit. Am J Epidemiol (1981) 0.96
Oligo(A) sequences of human respiratory syncytial virus G protein gene: assessment of their genetic stability in frameshift mutants. J Virol (1994) 0.96
Two outbreaks of herpes simplex virus type 1 nosocomial infection among newborns. J Clin Microbiol (1986) 0.96
Functional significance of concomitant inactivation of hMLH1 and hMSH6 in tumor cells of the microsatellite mutator phenotype. Proc Natl Acad Sci U S A (2001) 0.96
Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes. J Med Virol (2004) 0.94
Genotyping of clinical herpes simplex virus type 1 isolates by use of restriction enzymes. J Clin Microbiol (2006) 0.94
Impairment of double-strand breaks repair and aberrant splicing of ATM and MRE11 in leukemia-lymphoma cell lines with microsatellite instability. Cancer Sci (2006) 0.93
Reiterated sequences of herpes simplex virus type 1 (HSV-1) genome can serve as physical markers for the differentiation of HSV-1 strains. Arch Virol (1989) 0.92
Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Antiviral Res (2005) 0.90
Patterns of Eurasian HSV-1 molecular diversity and inferences of human migrations. Infect Genet Evol (2005) 0.90
Characterization of human cytomegalovirus strains by analysis of short tandem repeat polymorphisms. J Clin Microbiol (2001) 0.88
Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Invest Ophthalmol Vis Sci (2002) 0.87
Divergence of reiterated sequences in a series of genital isolates of herpes simplex virus type 1 from individual patients. J Gen Virol (2003) 0.86
Human cytomegalovirus (HCMV) short tandem repeats analysis in congenital infection. J Clin Virol (2005) 0.84
Variable restriction endonuclease sites of herpes simplex virus type 1 isolates from encephalitic, facial and genital lesions and ganglia. J Gen Virol (1983) 0.82
PCR analysis of human telomeric repeats present on HHV-6A viral strains. Virus Genes (1997) 0.77
Close association of predominant genotype of herpes simplex virus type 1 with eczema herpeticum analyzed using restriction fragment length polymorphism of polymerase chain reaction. J Virol Methods (2003) 0.77
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. Antimicrob Agents Chemother (1998) 3.02
Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbiol (1991) 2.16
Autism, language delay and mental retardation in a patient with 7q11 duplication. J Med Genet (2007) 1.86
Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet (2008) 1.83
Activities of several antimicrobials against Mycobacterium ulcerans infection in mice. Antimicrob Agents Chemother (2000) 1.79
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. AIDS (1999) 1.75
Concomitant infection by human herpesvirus 6, HTLV-I, and HIV-2. Lancet (1988) 1.66
High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapy. Am J Transplant (2011) 1.60
K-complex-induced seizures in autosomal dominant nocturnal frontal lobe epilepsy. Clin Neurophysiol (2008) 1.47
Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease. N Engl J Med (1995) 1.34
Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure. Virology (2002) 1.34
Susceptibility of HIV-1 isolates to zidovudine: correlation between widely applicable culture test and PCR analysis. J Acquir Immune Defic Syndr (1992) 1.25
Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure. AIDS (2001) 1.24
SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years. Neurology (2006) 1.22
Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. Neurology (2006) 1.20
De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. Neurology (2010) 1.20
Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and Golgi morphogenesis. Mol Cell Neurosci (2007) 1.19
Multicentre quality control of polymerase chain reaction for detection of HIV DNA. AIDS (1992) 1.18
Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor. J Clin Microbiol (1999) 1.12
Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Transl Psychiatry (2012) 1.08
Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals. Virology (2000) 1.08
PRRT2 mutations and paroxysmal disorders. Eur J Neurol (2013) 1.08
Puzzles concerning the pathogenicity of human herpesvirus 6. N Engl J Med (1993) 1.06
Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection. Sex Transm Infect (2006) 1.06
Antigenic and genetic differentiation of the two putative types of human herpes virus 6. J Virol Methods (1993) 1.06
Definition and distribution analysis of glycoprotein B gene alleles of human herpesvirus 7. J Virol (1998) 1.05
Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma. AIDS Res Hum Retroviruses (1996) 1.05
Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen. AIDS (1999) 1.04
New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients. J Infect Dis (2000) 1.02
Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice. Antimicrob Agents Chemother (2000) 1.02
Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet (2005) 1.01
Recombination and rescue between temperature-sensitive mutants of poliovirus type 1. Virology (1984) 0.99
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus. J Clin Microbiol (1999) 0.97
Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections. J Clin Microbiol (2009) 0.97
Frequency of early in utero HIV-1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS (1995) 0.97
Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis. Cytometry (2000) 0.96
HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression. AIDS Res Hum Retroviruses (2001) 0.95
High variability of the gag/pol transframe region among HIV-1 isolates. C R Acad Sci III (1994) 0.94
Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations. Neurology (2009) 0.93
Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections. J Clin Virol (2003) 0.93
Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo. J Gen Virol (2001) 0.92
Comparison of capillary electrophoresis sequencing with the new CEQ 2000 DNA Analysis System to conventional gel based systems for HIV drug resistance analysis. J Virol Methods (2001) 0.92
Detection of human Betaherpesvirinae in saliva and urine from immunocompromised and immunocompetent subjects. J Clin Microbiol (1997) 0.92
Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection. Ann Intern Med (1998) 0.90
Biochemical characterization of poliovirus type 1 temperature-sensitive mutants. Virology (1984) 0.90
Comparative assessment of quantitative HIV viraemia assays. AIDS (1992) 0.90
Prevalence of human herpesvirus-6 chromosomal integration (CIHHV-6) in Italian solid organ and allogeneic stem cell transplant patients. Am J Transplant (2009) 0.90
Monitoring of human cytomegalovirus infection in immunosuppressed patients using real-time PCR on whole blood. J Clin Virol (2007) 0.89
Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patients. J Clin Microbiol (1999) 0.89
Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr. Virology (2001) 0.89
Short-term evaluation of zidovudine-treated patients: decrease in plasma and cellular viraemia titres. AIDS (1992) 0.89
Isolation of atypical HIV-1-related retrovirus from AIDS patient. Lancet (1992) 0.88
Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group. J Med Virol (1999) 0.88
Rate of detection of human herpesvirus-6 at different stages of HIV infection. Eur J Clin Microbiol Infect Dis (1995) 0.88
A poliovirus mutant defective for self-cleavage at the COOH-terminus of the 3C protease exhibits secondary processing defects. Virology (1988) 0.88
Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Côte d'Ivoire, 2010. Br J Cancer (2012) 0.87
Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1 thymidine kinase gene. Exp Eye Res (2000) 0.87
Herpesvirus 6 infection in young children. N Engl J Med (1992) 0.87
Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy. Antivir Ther (2001) 0.86
Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes. Hepatology (1998) 0.86
Detection of human herpes virus 6 in AIDS-associated retinitis by means of in situ hybridization, polymerase chain reaction and immunohistochemistry. J Med Virol (1996) 0.85
Intrauterine transmission of human herpesvirus 6. Lancet (1992) 0.85
Use of inverse polymerase chain reaction to characterize a novel human herpesvirus 7 isolate. J Virol Methods (1997) 0.85
Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization. J Med Virol (1998) 0.85
Two PBMC-based neutralization assays depict low reactivity of both anti-V3 monoclonal antibodies and immune sera against HIV-1 primary isolates. J Virol Methods (1997) 0.85
Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice. Antimicrob Agents Chemother (2001) 0.84
Microsatellite analysis of HSV-1 isolates: from oropharynx reactivation toward lung infection in patients undergoing mechanical ventilation. J Clin Virol (2010) 0.84
Detection of HHV-6 by the polymerase chain reaction. J Virol Methods (1991) 0.83
Human herpesvirus-8 seroconversions after renal transplantation. Transplantation (2001) 0.83
Simplified enzyme-linked immunosorbent assay for specific antibodies to respiratory syncytial virus. J Clin Microbiol (1986) 0.83
Recent advances in amino acid analysis by capillary electrophoresis. Electrophoresis (2001) 0.82
Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome. Clin Infect Dis (2001) 0.82
Genetic variability affects the detection of HIV by polymerase chain reaction. AIDS (1991) 0.82
Identification of human herpesvirus 6 variants A and B by amplimer hybridization with variant-specific oligonucleotides and amplification with variant-specific primers. J Clin Microbiol (1994) 0.81
Intratypic recombination of polioviruses: evidence for multiple crossing-over sites on the viral genome. J Virol (1987) 0.81
[An atypical presentation of Kikuchi-Fujimoto disease]. Rev Med Interne (2012) 0.81
Lack of evidence of any association between human herpesvirus 8 and various skin tumors from both immunocompetent and immunosuppressed patients. Arch Dermatol (1997) 0.81
Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol (1999) 0.81
Selection and characterization of two specific monoclonal antibodies directed against the two variants of human herpesvirus-6. Res Virol (1999) 0.81
Yellow fever 5' noncoding region as a potential element to improve hepatitis C virus production through modification of translational control. Biochem Biophys Res Commun (1998) 0.81
Unusual consequences of status epilepticus in Dravet syndrome. Seizure (2010) 0.81
Difference in permissiveness of human fibroblast cells to variants A and B of human herpesvirus-6. Res Virol (1996) 0.81
Controlled study of human herpesvirus 6 detection in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma. The French Study Group for HIV-Associated Tumors. J Med Virol (1995) 0.80
HHV-6 and multiple sclerosis. Nat Med (1998) 0.80
In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.80
Influenza hemagglutinin mediated fusion of membranes containing poly(ethylene-glycol) grafted lipids: new insights into the fusion mechanism. FEBS Lett (1999) 0.80
Multiple mutations involved in the phenotype of a temperature-sensitive small-plaque mutant of poliovirus. Virology (1987) 0.80
Dose-dependent systemic human immunodeficiency virus infection of SCID-hu mice after intraperitoneal virus injection. Res Virol (1995) 0.80
Maribavir use in practice for cytomegalovirus infection in French transplantation centers. Transplant Proc (2013) 0.79